COMMUNIQUÉS West-GlobeNewswire

Proteostasis Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
21/12/2017
CAMBRIDGE, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (Nasdaq: PTI ), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to [...]
Humanigen Signs Definitive Agreements to Exchange Loan Obligations for Equity
21/12/2017
Transactions Create Biotechnology Company Focused on Immunotherapy and Oncology Lenzilumab Begins Development for Treating Key Side-Effects Associated with CAR-T BRISBANE, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) -- [...]
Integra LifeSciences to Present at the 36th Annual J.P. Morgan Healthcare Conference
21/12/2017
PLAINSBORO, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ), a leading global medical technology company, today announced President and Chief Executive Officer Peter [...]
Ascendis Pharma A/S Announces Participation in 36th Annual J.P. Morgan Healthcare Conference
21/12/2017
COPENHAGEN, Denmark, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare [...]
Fluidigm Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that the Compensation Committee of its Board of Directors, which is comprised entirely of independent [...]
ZIOPHARM to Present at the 36th Annual J.P. Morgan Healthcare Conference
21/12/2017
BOSTON, Dec. 21, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the 36 th Annual J.P. Morgan Healthcare [...]
GenMark Diagnostics to Present at the J.P. Morgan 36th Annual Healthcare Conference
21/12/2017
CARLSBAD, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK ), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief [...]
Altimmune to Participate in the 10th Annual Biotech Showcase in San Francisco, January 8 – 10, 2018
21/12/2017
GAITHERSBURG, Md., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, announced today that Bill Enright, President and Chief Executive Officer, will provide a [...]
Antares Pharma Provides XYOSTED™ Regulatory Update
21/12/2017
EWING, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) today announced that a written request for a Type A meeting, along with a comprehensive briefing document, have been submitted to the U [...]
ProPhase Labs, Inc. Announces Final Results of Its Tender Offer
21/12/2017
DOYLESTOWN, Pa., Dec. 21, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH ) ( www.ProPhaseLabs.com ), a diversified natural health medical science company (“ProPhase”), announced today the final results of [...]
BriaCell Announces Closing of Warrant Incentive Program
21/12/2017
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER U.S. NEWSWIRE SERVICES BERKELEY, Calif. and VANCOUVER, British Columbia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (" BriaCell " or the " Company [...]
Burcon Announces Appointment of David Ju to Its Board of Directors
21/12/2017
VANCOUVER, British Columbia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Corporation”) is pleased to announce the appointment of Mr. David Ju as an [...]
Arzeda Strengthens Board of Directors with Addition of Biotechnology Veteran William Baum
21/12/2017
SEATTLE, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Arzeda , The Protein Design Company TM , today announced that biotechnology veteran William “Bill” Baum has joined the company’s board of directors. Baum is a highly respected [...]
Yield10 Bioscience Announces Closing of $14.5 Million Public Offering
21/12/2017
WOBURN, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today announced the closing of an underwritten public offering of units for gross proceeds of $14.5 million, which includes the [...]
Sensorion Successfully Closes on a €1.6 Million Euro Placement with Cochlear
21/12/2017
MONTPELLIER, France, Dec. 21, 2017 (GLOBE NEWSWIRE) -- (FR0012596468 — ALSEN) — Sensorion, a biotech specializing in the treatment of inner ear diseases (the "Company"), announces that it has today carried out a capital [...]
Emerald Health Therapeutics Receives $26.5 Million from Exercise of Warrants and Triggers Acceleration of 721,700 Remaining $2.00 Warrants
21/12/2017
VICTORIA, B.C., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (“Emerald” or the “Company”) (TSX-V: EMH ) (OTCQX:EMHTF) has elected to exercise its right to accelerate the exercise of $2.00 common [...]
Crown Bioscience Announces Merger with JSR Corporation
21/12/2017
SAN DIEGO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing [...]
One-Year Follow-Up Shows 71.4% Progression-Free Survival in 14 Prostate Cancer Patients Treated with ProscaVax in Phase 1 Clinical Trial
21/12/2017
BATON ROUGE, La., Dec. 21, 2017 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of a proprietary [...]
ImmuCell Corporation Announces Closing of $3 Million Public Offering of Common Stock
21/12/2017
PORTLAND, Maine, Dec. 21, 2017 (GLOBE NEWSWIRE) -- ImmuCell Corporation (“ImmuCell” or the “Company”) (Nasdaq: ICCC ), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]

Pages